Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
On the occasion of the completion of 75 years of making the Constitution, a two-day discussion wi
The Government of India on Thursday said that the Archaeological Survey of India (ASI) is continu
The Mumbai Indians team will never want to remember their IPL 2024 performance. Mumbai Indians&nb
After Salman Khan and Shahrukh Khan, now Bhojpuri actress Akshara Singh has received death threat
Prime Minister Narendra Modi on Sunday once again expressed concern about digital fraud and cyber
Royal Challengers Bangalore has won the IPL 2025 title. In the final, RCB defeated Punjab Kings b
Among the 14 amendments accepted by the Joint Committee (JPC) of Parliament on the Waqf (Amendmen
Tamil Nadu stampede case: Supreme Court to hear today, Madras High Court order challenged
The Supreme Court will hear a petition filed by Tamil actor Vijay's political party, Tamilaga Vet
Pakistan's start in the T20 World Cup 2024 has been very embarrassing. Co-host USA defeated Pakis
Following the violence in Nagpur, the Maharashtra Cyber Department has identified more than
